The drug, named lenacapavir, targets the structure and function of HIV's capsid protein. It protects people for 6 months with each shot. Unlike mainstay HIV drugs that disrupt viral enzymes by binding ...
Researchers are shining a light on cancer cells' energy centers -- literally -- to damage these power sources and trigger widespread cancer cell death. In a new study, scientists combined strategies ...
Zhou's lab cracked the code five years ago by figuring out how to exploit the inner membrane's vulnerability – an electrical charge differential that keeps its structure intact and functions on track ...